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ABSTRACT
Objective: Adequate isolation of nucleic acids from peripheral blood, fine-needle aspiration 
cells in stained slides, and fresh and formalin-fixed/paraffin-embedded tissues is crucial to en-
sure the success of molecular endocrinology techniques, especially when samples are stored 
for long periods, or when no other samples can be collected from patients who are lost to 
follow-up. Here, we evaluate several procedures to improve current methodologies for DNA 
(salting-out) and RNA isolation. Materials and methods: We used proteinase K treatment, heat 
shock, and other adaptations to increase the amount and quality of the material retrieved from 
the samples. Results: We successfully isolated DNA and RNA from the samples described abo-
ve, and this material was suitable for PCR, methylation profiling, real-time PCR and DNA se-
quencing. Conclusion: The techniques herein applied to isolate nucleic acids allowed further 
reliable molecular analyses. Arq Bras Endocrinol Metab. 2012;56(9):618-26  
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RESUMO
Objetivo: O isolamento adequado de ácidos nucleicos a partir de sangue periférico, lâmina co-
rada de punção aspirativa por agulha fina, tecido fixado em formalina e emblocado em parafina 
e tecido fresco é fundamental para assegurar o sucesso de técnicas aplicadas em endocrinolo-
gia molecular, principalmente quando lidamos com amostras estocadas por longos períodos 
ou quando há impossibilidade de nova coleta de amostra de pacientes que perderam o se-
guimento. Neste trabalho, objetivamos otimizar as metodologias clássicas para a extração de 
DNA (salting-out) e RNA. Materiais e métodos: Utilizamos proteinase K, choque térmico, dentre 
outras modificações, com o objetivo de aumentar a quantidade e a qualidade do material recu-
perado a partir das amostras descritas acima. Resultados: Isolamos com sucesso DNA e RNA 
de tais amostras e o material obtido foi adequado para a realização de PCR, perfil de metilação, 
PCR em tempo real e sequenciamento de DNA. Conclusão: As técnicas aplicadas neste estudo 
para isolar ácidos nucleicos permitiram a realização posterior de análises moleculares consis-
tentes e confiáveis. Arq Bras Endocrinol Metab. 2012;56(9):618-26
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INTRODUCTION
A dvances in molecular biology have promoted the routine use of techniques such as PCR, real-time 
PCR, and DNA sequence analysis for the detection 
of mutations in a large variety of human diseases (1). 
In molecular endocrinology, these approaches are of 
enormous importance for the diagnosis of inherited 
disease-causing mutations and/or somatic mutations. 
Therefore, the adequate isolation of nucleic acids from 
peripheral blood, fine-needle aspiration (FNA) cells in 
stained slides, and fresh and formalin-fixed/paraffin-
embedded (FFPE) tissues is crucial to ensure the suc-
cess of these techniques, posing a challenge for routine 
DNA extraction protocols, especially when blood sam-
ples and FFPE tissues have been stored for long period, 
and when no other samples can be collected from pa-
tients lost to follow-up (2,3). 
Ideally, DNA and RNA isolation methods should 
maximize nucleic acid yield, and isolated material 
should be usable in all downstream molecular applica-
tions (3). However, some extraction methods used in 
commercial kits have relatively poor recovery of DNA 
from blood samples stored longer than 3 months, for 
example. Moreover, lab protocols based exclusively on 
commercial kits are generally insufficient to promptly 
overcome these limitations.
DNA and RNA isolated from cells in stained slides 
are very important due to possible molecular testing in 
conjunction with cytology, especially when the latter re-
veals indeterminate lesions (4). Furthermore, obtaining 
DNA and RNA from FFPE samples and stained slides 
is always a challenge because fixation, embedding, stai-
ning, and extraction methods generally inhibit nucleic 
acid retrieval from the samples (3). On the other hand, 
although formalin fixation may degrade nucleic acids, 
it also deactivates nucleases and, thus, has a stabilizing 
effect (3).
Although a number of studies have reported pro-
mising results in optimizing commercial kits using 
automated or manual DNA extraction methods, little 
has been published about the optimization of in-hou-
se nucleic acid extraction methods. Here, we report 
adaptations carried out in procedures to obtain greater 
amount of DNA and RNA of better quality extracted 
from several sources. Because our research is focused 
on thyroid disorders, including thyroid cancer, we used 
PCR, real-time PCR, methylation profiling, and direct 
sequencing analyses of the RET, BRAF and HES1 ge-
nes as examples to demonstrate and validate such im-
provements. 
METHODS AND RESULTS
DNA isolation from fresh and long-term stored blood 
samples, FFPE tissue samples, FNA cells in stained 
slides and cultured cells 
Fresh whole blood
We extracted genomic DNA using a method modified 
from Bowtell (5). A 300-µL fresh whole-blood sample 
was mixed with 900 µL of buffer A (20 mM Tris-HCl 
pH 7.6) to promote red blood cell lysis for 10 min at 
room temperature (RT). After centrifugation for 1 min 
at 15,600 xg at RT, the supernatant was removed, and 
the pellet was resuspended in 600 µL of cold buffer 
B (10 nM Tris-HCl pH 8.0, 1 mM EDTA pH 8.0, 
0.1% w/v SDS), which contains denaturing agents for 
cell lysis. The pellet was then pipetted up and down 
until it was completely dissolved. Next, the sample was 
submitted to heat shock (incubation at -70°C for 20 
min followed by 66°C for 20 min), followed by treat-
ment with 5 µL of proteinase K (10 mg/ml) at 66°C 
for 1 hour and at RT for 15 min. For protein precipita-
tion, 200 µL of solution C were added (5M potassium 
acetate, 11.5% glacial acetic acid), and the sample was 
then vortexed vigorously for 20 s and centrifuged for 5 
min at 15,600 xg. The supernatant was transferred to 
a clean microcentrifuge tube and mixed with 600 µL 
of isopropanol and, when necessary, 1 µL of glycogen 
(20 mg/µL), as well, mixed by manual inversion. After 
centrifugation at 15,600 xg for 2 min, a DNA-glycogen 
pellet was observed, and the supernatant was removed. 
After the pellet was washed with 70% ethanol, centrifu-
ged, and air-dried, it was resuspended in TE (10 mM 
Tris-HCl, 1 mM EDTA, pH 7.6). Resuspension can be 
optimized by incubation at 65°C for 60 min, or over-
night. DNA extraction can also be enhanced by blood 
subfractionation, and selection of the leukocyte layer 
(the buffy coat after 10-min centrifugation at 2,880 xg). 
If the first nucleic acid extract was still rich in con-
taminants (protein or lipids), a  phenol-chloroform-i-
soamyl re-extraction was performed. After centrifu-
gation with  phenol-chloroform, the aqueous phase 
containing the nucleic acid was re-extracted with equal 
volumes of chloroform-isoamyl alcohol, followed by a 
series of 100% and 70% ethanol washes.
DNA and RNA extraction from several sources
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Long-term stored blood
For DNA extraction from blood samples that were sto-
red for long periods, we modified several steps of the 
process, such as the use of three incubation periods with 
buffer A (to promote red cell lysis). Moreover, a longer 
incubation time for the heat shock is also necessary (2 
hours at both temperatures), as well as an overnight 
incubation with proteinase K at 66°C. Figure 1 shows 
DNA isolated from long-term stored blood compared 
with DNA isolated from fresh blood samples. 
pellet was washed with 100% ethanol and subsequently 
with 70% ethanol, combined with incubation for 1 min 
at RT, followed by centrifugation for 5 min at 15,600 
xg, and finally air-dried at 37°C. For cell lysis, we added 
600 µL of cold buffer B and 2.5 µL of proteinase K 
(20 mg/mL), mixed by inversion, and incubated the 
mixture for 2 hours at 56°C. Proteinase K was inacti-
vated by incubating the sample at 95°C for 10 min and 
transferring it to ice for 1 min. For DNA purification, 
we used 200 µL of solution C, inverted the sample and 
centrifuged it for 5 min at 15,600 xg. The supernatant 
was transferred to a clean microcentrifuge tube and sub-
mitted to the steps described above for genomic DNA. 
Results are shown in figure 1, and compared with sam-
ples treated with commercial kit in figure 2.
Figure 1. Agarose gel (1.8%) electrophoresis of total DNA isolated from 
fresh blood (A), long-term stored blood (B), fresh tissue (C), FFPE tissue 
(D), bisulfite treated DNA from FFPE tissue (E), B104 cells (F), and FNA 
cells in stained slides (G). DNA concentration and quality were evaluated 
using Nanodrop2000 (Thermo Scientific, Wilmington, DE, USA) to measure 
absorbance at 260 and 280 nm. Compared with DNA recovered from 
fresh blood (lane A), long-term stored blood seems to be more degraded 
and produces smeared bands (lane B). DNA recovered from FFPE tissue 
(lane D) appears as a light smear, and the DNA concentration is lower than 
that obtained from fresh and long-term stored blood, as expected. In lane 
E, DNA smears are even lighter after bisulfite treatment. Minor smearing 
can be noted in DNA recovered from cells (lane F), although less extensive 
than that observed for long-term stored blood, FFPE tissue and bisulfite-
treated DNA. Furthermore, DNA isolated from cells and fresh blood 
exhibited greater concentration and quality, suggesting little degradation 
and preserved structure. Most of the DNA isolated from FNA cells in 
stained slides, unlike DNA isolated from other samples, migrated to the 
bottom of the electrophoresis gel (lane G).
Figure 2. Representative histogram showing the total amount of DNA 
directly measured by spectrophotometry (upper panel) and correlated DNA 
quality analysis in 1.8% electrophoresis agarose gel (bottom panel) after 
loading 400 ng of DNA from each different source per lane. A: DNA isolated 
from B104 cell line (lanes 1-3), FFPE tissue (lanes 4-6) and FNA cells in 
stained slides (lanes 7-9) using three tested protocols; commercial kit (lanes 
1, 4 and 7), TRIzol™ RNA/DNA standard co-extraction (lanes 2, 5, and 8), 
and in-house modified salting-out (lanes 3, 6, and 9). B: Total DNA obtained 
from FFPE tissue (lanes 1 and 2) and FNA cells in stained slides (lanes 3 and 
4), using TRIzol™ RNA/DNA standard co-extraction (lanes 1 and 3) and 
TRIzol™ RNA/DNA in-house optimized co-extraction (lane 2 and 4). 
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Formalin-fixed/paraffin-embedded tissues
For FFPE tumor tissues, we performed some adapta-
tions to enhance the yield of recovered DNA. For each 
sample, one 10-µm tissue slice was deparaffinized by 
means of two xylene (1 mL) baths at 65°C for 30 min 
with periodic inversion, followed by centrifugation for 
5 min at 15,600 xg and removal of the supernatant. The 
FNA cells in stained slides
DNA extraction from thyroid FNA stained slides follo-
wed the in-house protocol; however, the method was 
modified by resuspending the cells in 300 µL of cold 
buffer B, pipetting up and down and scraping, followed 
by transfer to a clean microcentrifuge tube. Next, 1.5 
µL of proteinase K (10 mg/mL) were added, mixed by 
DNA and RNA extraction from several sources
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inversion, and incubated at 55°C  for at least 2 hours 
(up to overnight). Proteinase K was inactivated at 95°C 
for 10 min, and the sample was incubated on ice for 1 
min. To precipitate the protein in the sample, 100 µL 
of solution C were added, and the sample was vortexed 
for 20 s, incubated for 5 min on ice and centrifuged for 
3 min at 15,600 xg. The supernatant was transferred 
to a clean microcentrifuge tube, mixed with 300 µL 
of isopropanol and 0.5 µL of glycogen (20 mg/µL) 
by inversion, and centrifuged for 5 min at 15,600 xg. 
The next steps were the same used for genomic DNA 
extraction described above.
Cultured cells
To isolate DNA from cells in culture (1-2x106 to 
1-2x107), neither buffer A nor proteinase K are neces-
sary. To improve the protocol, we removed the growth 
medium from the culture dish, washed the cells with 
1 mL 1xPBS to remove residual medium and added 1 
mL 1xPBS to detach the cells. For adherent cells, we 
first treated the culture with 1 mL trypsin for 5 min 
at 37°C, and then inactivated trypsin by adding 3 mL 
of medium. After transferring the cells (resuspended in 
PBS) to a labeled microcentrifuge tube, we centrifu-
ged the sample for 30 s at 15,600 xg and removed the 
supernatant, leaving approximately 20 µL of residual 
liquid. The pellet was then resuspended by vortexing. 
Buffer B (300 µl) was added, and the sample was pipet-
ted up and down to completely lyse the cells, followed 
by the addition of 100 µL of buffer C. The tube was 
inverted and centrifuged for 1 min at 15,600 xg. The 
supernatant was transferred to a clean microcentrifuge 
tube and submitted to the steps described above for 
genomic DNA, but with only half the volume of iso-
propanol and ethanol. 
RNA isolation from blood, fresh and FFPE tumor 
tissue, FNA cells in stained slides and cell lines 
Fresh whole blood
Samples of 3 mL of peripheral whole blood were col-
lected from patients in tubes with EDTA. For each 
250 µL of peripheral blood collected, 750 µL of TRI-
zol LS™ reagent (Life Technologies, Carlsbad, CA, 
USA) was added to a clean microcentrifuge tube. Du-
ring this step, it is important to avoid touching the 
tube wall to prevent the formation of clots, which de-
creases the extraction yield. The sample was homoge-
nized by vortexing for 10 s (this must be performed 
immediately after adding the blood to prevent clot 
formation) and incubated for 5 min at RT. For each 
750 µL of TRIzol LS™ reagent used for homogeni-
zation, 200 µL of chloroform were added, and the 
sample was vortexed until it became turbid, followed 
by incubation at RT for 15 min. Then, the tube was 
centrifuged at 12,000 xg for 15 min at 4°C to separa-
te the mixture into phases. The aqueous phase, which 
contained exclusively RNA, was removed and placed 
into a new tube before proceeding with isolation. For 
isolation, 500 µL of 100% isopropanol were added 
to the RNA-containing phase and incubated overni-
ght at -20°C. The samples were then centrifuged at 
12,000 xg for 10 min at 4°C. The supernatant was 
removed by inversion, and the RNA pellet was wa-
shed twice with 1 mL of 75% ethanol; each wash was 
followed by centrifugation at 7,400 xg for 5 min at 
4°C. The supernatant was discarded, and the pellet 
was air-dried and resuspended in 10-30 µL of RNase-
-free water (depending on the size of the pellet). Re-
suspension was optimized by incubation at 55-60°C 
for 10 min. 
Fresh tumor tissues
Before extracting total RNA from tissue, the samples 
were weighed, defrosted at RT, and cut into small pie-
ces using sterilized scissors. A 1 mL of TRIzol™ rea-
gent was added for each 0.1 g of tissue, and the sam-
ples were homogenized with Polytron PT MR3100 
(Kinematica AG, Littau, CH) at 11,200 xg until the 
tissue dissolved completely. Then, 200 µL of chloro-
form were added; the subsequent steps were the same 
described above for total RNA extraction from peri-
pheral blood.
Formalin-fixed/paraffin-embedded tissues
To increase the yield of RNA recovered from FFPE tu-
mor tissues, we performed the same initial adaptations 
used for DNA isolation. Each 10-µm tissue slice was 
deparaffinized, washed with 100% and 70% ethanol and 
air-dried. Then, 1 mL of TRIzol™ reagent was added. 
The subsequent steps were the same used to isolate to-
tal RNA from fresh blood. 
FNA cells in stained slides 
To extract RNA from FNA stained slide samples, we 
resuspended the cells in 1 mL of TRIzol™ reagent by 
scraping attached cells and pipetting up and down. 
DNA and RNA extraction from several sources
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Two washes with 70% ethanol were performed to in-
crease the RNA yield, and to diminish interfering colo-
ration of the precipitated pellet. The subsequent steps 
were the same used to isolate total RNA from periphe-
ral blood.
Cultured cells 
For cells in culture (1-2x106 to 1-2x107), we first remo-
ved the growth media and washed the cells with 1xPBS, 
as described above, and then added 1 mL of TRIzol™ 
reagent per 10 cm2 of culture dish surface area. This 
cell detaching and lysing step was performed directly 
in the culture dish by pipetting up and down several 
times to ensure the complete dissolution of the cells. 
Next, 200 µL of chloroform were added. The subse-
quent steps were the same used to isolate total RNA 
from peripheral blood.
RNA/DNA in-house optimized co-extraction from FNA 
cells in stained slides and FFPE tumor tissues
Using standard TRIzol™ protocol for co-extraction 
of RNA/DNA from FNA cells in stained slides and 
FFPE tumor tissues, DNA from two out of seven sam-
ples was not suitable for subsequent use. To improve 
this recovery, after centrifugation for RNA and DNA 
separation in two phases, we extracted RNA following 
the manufacturer’s procedures, and precipitated DNA 
by adding 400 µL of 100% ethanol, incubating the 
mixture for 3 min at RT, and centrifuging the sample 
DNA and RNA extraction from several sources
Figure 3. Schematic representation of the major steps for TRIzol™ RNA/DNA in-house optimized co-extraction. RNA and DNA in TRIzol™ are normally 
separated in an upper and a lower phase, respectively. After that, RNA can be extracted following manufacturer’s standard procedures, and DNA can be 
re-extracted from the lower phase, by means of optimization using our in-house modified salting-out method. 
at 2000 xg for 20 min at 4°C.The DNA pellet was 
re-extracted using our in-house method. These steps 
are represented in figure 3. DNA from FNA cells in 
stained slides and FFPE tissues presented better qua-
lity when compared with standard TRIzol™ protocol 
(Figure 2).
Polymerase chain reaction 
DNA was amplified in 25-µL PCR reactions containing 
10 pM of each specific primer, 10 mM Tris-HCl (pH 
8.3), 50 mM KCl, 200 µM dNTP, 1.5 µM MgCl2, 0.2 
U Taq DNA polymerase (Invitrogen, Carlsbad, CA, 
USA). Primers are rigorously designed to avoid SNP 
regions, using the publicly available primer design me-
thod at http://ihg.gsf.de/ihg/ExonPrimer.html. The 
amplification of DNA isolated from FNA cells in stai-
ned slides and FFPE tissues successfully demonstrated 
the quality of the in-house extraction protocol to reco-
ver DNA from these samples (Figure 4).
Bisulfite DNA sequencing for methylation analysis
The bisulfite conversion of genomic DNA was per-
formed using the Methylcode Bisulfite Conversion 
Kit (Invitrogen). After bisulfite conversion, the 
HES1 promoter region was amplified using bisulfi-
te-PCR oligonucleotides that were designed using 
MethylPrimer Express Software (Applied Biosystems, 
Foster City, CA, USA). PCR products were cloned 
into the pCR4 vector (Topo TA Cloning Kit, In-
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Figure 4. Agarose gel (1.8%) electrophoresis of PCR products. A: exon 
15 of the BRAF gene (245 bp) amplification using DNA samples (1, 2 and 
3) of FNA cells in stained slides; (+) positive control, (-) negative control. 
B: amplification of exon 10 of the RET gene (374 bp) using DNA samples 
(1 and 2) from FFPE tissue. 
100 bp100 bp
A B
1 12 23 + -
vitrogen), transformed into DH5’-T1 chemically 
competent cells, and plated under antibiotic selec-
tion. Plasmid DNA from isolated colonies was ex-
tracted with QIAPrep Spin Miniprep Kit (Qiagen, 
Valencia, CA, USA) and sequenced to determine 
HES1 promoter methylation status. Multiple inde-
pendent clones were sequenced for each of the am-
plified fragments.  
Direct sequencing of PCR products
PCR products were resolved by electrophoresis in aga-
rose gel, purified using the Illustra GFX PCR DNA 
and Gel Purification Kit (GE Healthcare, Buckingha-
mshire, UK), and submitted to direct sequencing by 
the Sanger method, using the Big Dye™ Terminator 
Cycle Sequencing Ready Reaction Kit and an ABI 
PRISM 3130 xl Genetic Analyzer (Applied Biosyste-
ms). Each exon was sequenced at least twice and in 
both directions. 
The sequences were analyzed in the BioEdit Se-
quence Alignment Editor and CLC Main Workbench 
6 (http://www.clcbio.com) and compared with refe-
rence data available from the NCBI GenBank and the 
Ensembl Genome Browser. For somatic mutations, we 
referred to the Catalog of Somatic Mutations in Cancer 
(COSMIC) database (http://www.sanger.ac.uk/gene-
tics/CGP/cosmic/). Bisulfite sequencing data were 
analyzed using BiQ Analyzer software v16. To avoid 
misinterpretation, two different readers analyzed all 
results.
The HES1 promoter region was amplified from 
DNA extracted from FFPE medullary thyroid cancer tis-
sues treated with sodium bisulfite, and the resulting PCR 
products were directly sequenced (Figures 5 and 6).
DNA and RNA extraction from several sources
Figure 5. Agarose gel (1.8%) electrophoresis of PCR products 
representing the promoter region of HES1 (180 bp). A-E: DNA samples 
from FFPE medullary thyroid cancer treated with sodium bisulfite used as 
templates. Despite the fragmentation of the DNA in FFPE tissue, 
amplification after treatment with sodium bisulfite was successful, making 
epigenetic studies possible.
100 bp A B C D E
Figure 6. Direct sequencing of the HES1 promoter region (180 bp) from 
DNA samples of FFPE medullary thyroid cancer tissue after pretreatment 
with sodium bisulfite. A: whole converted sequence. B: highlighted 
unconverted bases. 
Reverse transcription reaction and real-time 
polymerase chain reaction
Between 0.5 and 1 µg of total RNA recovered from 
peripheral whole blood, tumor tissue, FFPE tissue, 
FNA cells in stained slides and cultured cells were 
used to perform the reverse transcription reaction. 
DNAse pretreatment was conducted to prevent con-
tamination with genomic DNA. Next, oligodT or 
random primers, 10 mM of each deoxyribonucleo-
side phosphate (dNTP), 5x first-strand buffer, 0.1 M 
dithiothreitol (DTT), RNAse Out Mix (Invitrogen), 
and 200 U reverse transcriptase (SuperScript II, Invi-
trogen) were added and reverse transcription was per-
formed at 65°C for 5 min, followed by 1.5 min on ice, 
60 min at 50°C, and 15 min at 70°C. Real-time PCR 
was carried out for the S8 gene in triplicate in a 20-µL 
reaction volume of 5-32 ng cDNA, 10 µL SYBR Green 
Master Mix (Applied Biosystems), and 10 pmol/L of 
each primer. Fluorescence intensity was quantified, and 
amplification plots were analyzed by a sequence detec-
tor system (ABI Prism 7500; Applied Biosystems), as 
shown in figure 7.
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DISCUSSION
With the growing interest in understanding the gene-
tic basis of many diseases, obtaining enough nucleic 
acid with reasonable quality for downstream molecular 
analysis is a constant challenge. In this report, we des-
cribe improvements to different procedures carried out 
in our research laboratory.
In-house protocols for DNA extraction modified 
from the salting-out technique, have been used for fre-
sh and long-term stored blood samples (6-9). Further-
more, long-term stored blood samples (1-10 years), 
which are normally discarded in clinical laboratories, 
can provide valuable material for genetic and epigenetic 
studies, reducing the number of samples required from 
the patient, thus saving time and lowering costs (8,10). 
As proposed by other authors (8,9), we chose heat 
shock, addition of proteinase K, longer incubations 
with buffer A, and vortexing as additional strategies to 
dissolve clots and isolate high quality DNA useful for 
further analysis. 
Analyses of DNA and RNA isolated from FFPE 
tumor tissue are useful for assessing disease etiology, 
mechanisms of carcinogenesis, and biomarkers for the 
prognosis and prediction of treatment responses (1). In 
this paper, we propose the use of this in-house protocol 
modified from Goelz and cols. (11) and Bowtell (5) to 
recover DNA from FFPE tissue samples, which resulted 
in higher yields of DNA with better quality when com-
pared with commercial kits, possibly due to the higher 
temperature used in the inactivation of proteinase K 
and subsequent heat shock, preventing the possible re-
tention of some DNA in the purification column. Ad-
ditionally, submitting the pellet of precipitated protein 
(after buffer C addition and centrifugation) to re-ex-
traction, we were able to isolate significant quantities of 
DNA, in the range of 300 ng/µL. We also noticed that, 
in some cases, amplification in PCR reactions was bet-
ter when using DNA extracted with the in-house pro-
tocol than when using DNA obtained with commercial 
DNA extraction kits, that produced amplicons as large 
as 374 bp, despite the frequent recommendation to de-
sign PCR products no larger than 150 to 200 bp (12). 
The use of DNA from FFPE tissue for epigenetic 
analysis can be challenging, as it is known to be highly 
fragmented, and can be even more degraded after bi-
sulfite treatment, often impairing further methylation 
profiling (13). Still, with better quality DNA, we have 
achieved effective amplification and sequencing of bi-
sulfite-treated GC-rich sequences of up to 489 bp in 
length, despite the recommendation to use fragments 
smaller than 150 bp in this kind of sample (13). 
The major limitations for RNA isolation from 
FFPE tissue samples are cross-linking between nucleic 
acids and proteins, and degradation promoted by for-
malin fixation. In general, pre-treatment with protei-
nase K and/or digestion buffer prior to RNA isolation 
procedures is recommended (14-20). In this regard, 
we have recovered RNA even without using these in-
termediate steps. These results were similar to those 
described by other groups using TRIzol™ reagent 
(19,21), while other groups were unable to achieve 
successful RNA recovery (22). It seems that the omis-
sion of deparaffinization and rehydration steps has 
improved the efficiency of real-time PCR (data not 
shown) by reducing sample cross-contamination from 
repeated pipetting, and by preventing the risk of RNA 
degradation (23).
For FNA analysis, obtaining material from the same 
sample that has been analysed by a cytopathologist is 
important to ensure clinically integrated morphologi-
cal and molecular diagnosis, especially because of the 
heterogeneity of thyroid tumors and the difficulty of 
obtaining identical FNA cytology results from multiple 
samples (4). DNA purification from FNA cells in stai-
ned slides has been reported to present methodological 
challenges, including low DNA quality and concen-
DNA and RNA extraction from several sources
Figure 7. Real-time PCR of the S8 gene from cDNA from fresh blood 
(beige line), TT cells (red line), FNA cells in stained slides (blue line), FFPE 
tissue (dark green), and long-term stored tissue (light green). As expected, 
FNA cells in stained slides, FFPE and long-term stored tissues presented 
higher threshold cycles, most likely due to lower RNA quality and integrity. 
Adaptations to improve the efficiency of these reactions should be 
pursued.
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tration, especially when using long-term stored slides, 
and fixation/staining procedures, which result in PCR 
inhibition (24). To improve current methodologies, we 
made some modifications to previously described pro-
tocols (6,25-27). Our FNA stained slides from thyroid 
nodules are routinely maintained at RT without cover-
slips, so pre-treatment with xylene and re-hydration by 
means of ethanol washes were not necessary. Instead of 
using cells resuspended in lysis buffer for PCR, as pro-
posed by some authors (28,29), we used purified and 
precipitated DNA. We believe that not exposing the 
cells to xylene and the heat shock step result in better 
DNA quality, improving PCR efficiency. As it is known, 
the use of the TRIzol™ protocol enables the recovery 
of both RNA and DNA. Thus, we made an effort to 
improve the amount of DNA by adding a step of DNA 
re-extraction, as shown in figure 3. This additional step 
in DNA extraction from TRIzol™-DNA phase, using 
buffers B and C, together with the final isopropanol/
ethanol precipitation, greatly improved the amount 
and quality of DNA obtained. As previously mentio-
ned, DNA and RNA extraction from cells in stained sli-
des ensures that the same sample that has been analysed 
by a cytopathologist is further analysed by molecular 
methods, which could be extremely relevant when dea-
ling with lesions of uncertain significance.    
Regarding the sequencing analysis of these samples, 
caution and rigor are essential to avoid genotyping er-
rors. The issue that we consider to be most concerning 
is allelic dropout, i.e., when only one of the two alle-
les present at a heterozygous locus is amplified (30), 
which may lead to false negative results. Low quality 
or quantity of DNA, chemical contaminants, and une-
ven PCR amplification of sequences with different GC 
contents can cause this phenomenon. To overcome this 
amplification bias, we routinely design primers accor-
ding to recent data on reference sequences to avoid 
including SNPs in primer binding sites. Other impor-
tant strategies include optimizing PCR reactions for 
low-stringency annealing temperatures to prevent the 
amplification of unspecific bands, together with the use 
of a high-fidelity, high-specificity and GC-rich perfor-
mance proof-reading DNA polymerase. Additionally, 
sequence analysis should be performed cautiously when 
evaluating SNP in heterozygosis; the absence of SNPs 
in an exon known to have many polymorphisms, or the 
presence of a homozygous SNP might suggest prefe-
rential PCR amplification. To minimize possible mis-
reading, we included at least two independent electro-
pherogram sequence readers, using different genome 
software analyzers. In addition, a second PCR/sequen-
cing reaction was performed to check the results.
CONCLUSION
In general, we propose the use of proteinase K and heat 
shock for fresh and long-term stored blood, FFPE tis-
sue, and FNA cells in stained slides for greater DNA 
yield. For RNA extraction from blood samples, we 
suggest measures to prevent clot formation. In addi-
tion, by making adaptations to the in-house and stan-
dard TRIzol™ protocols, and optimizing co-extraction 
of RNA and DNA from the same specimen, we suc-
cessfully isolated these nucleic acids sequentially from 
FFPE tissue and from long-term stored cells in stained 
slides (from fine-needle aspiration), which are known 
as scarce sources of nucleic acids of great importance 
for molecular diagnosis in endocrinology. DNA and 
RNA isolated from all these samples were suitable for 
PCR, methylation profiling, real-time PCR, and DNA 
sequencing analyses, enabling subsequent molecular 
diagnosis.  
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